The Use of the Selective Imidazoline I(1) Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity

Anti-cancer therapy based on the repeated administration of oxaliplatin is limited by the development of a disabling neuropathic syndrome with detrimental effects on the patient’s quality of life. The lack of effective pharmacological approaches calls for the identification of innovative therapeutic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurotherapeutics
Autors principals: Micheli, Laura, Di Cesare Mannelli, Lorenzo, Del Bello, Fabio, Giannella, Mario, Piergentili, Alessandro, Quaglia, Wilma, Carrino, Donatello, Pacini, Alessandra, Ghelardini, Carla
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7609613/
https://ncbi.nlm.nih.gov/pubmed/32572830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-020-00873-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars